MedPath

Evaluation of the efficacy of Zinc sulfate and fluoxetine in obsessive_compulsive

Phase 3
Conditions
Obssesive_compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20160530028182N11
Lead Sponsor
Kurdistan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

Age 10-17 years
Based on the diagnostic criteria of DSM-5, obsessive-compulsive disorder should be diagnosed in children by a specialist in child and adolescent psychiatry.

Exclusion Criteria

Existence of accompanying psychiatric disorder except for anxiety disorders and oppositional defiant disorder-
Mental retardation based on clinical suspicion
History of allergy to zinc sulfate
Wilson's disease according to medical statements and documents
Liver disease based on medical statements and documents
Spending drug treatments in the previous 2 months
Suicidal thoughts

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsessive compulsive scor in Fua et al.'s 2010 Obsessive Compulsive Questionnaire, Children's Version, 21 items (OCI-CV). Timepoint: At the beginning of the study, 4 weeks later, at the end of 8 weeks. Method of measurement: Fowa et al.'s 2010 Children's Version 21-item Obsession Questionnaire (OCI-CV).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath